Capreomycin sulfate labels and packages: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 23: | Line 23: | ||
{| | {| | ||
|- | |- | ||
| [[File: | | [[File:Capreomycin_4.jpg|800px|thumb]] | ||
|- | |- | ||
|} | |} | ||
Revision as of 00:30, 25 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Labels and Package
CAPASTAT® SULFATE Container Label Principal Display Panel Text:[1]
1 VIAL NDC 17478-080-50
CAPASTAT® SULFATE
CAPREOMYCIN FOR INJECTION, USP
Equivalent to 1 g Capreomycin Activity
Rx only
 |
CAPASTAT® SULFATE Carton Label Principal Display Panel Text:
CAPASTAT® SULFATE
CAPREOMYCIN FOR INJECTION, USP
Equivalent to 1 g Capreomycin Activity
FOR INTRAMUSCULAR AND INTRAVENOUS INFUSION ONLY
Rx only
References
- ↑ "CAPASTAT SULFATE (CAPREOMYCIN) INJECTION, POWDER, FOR SOLUTION [AKORN]". Text " accessdate " ignored (help)
Adapted from the FDA Package Insert.